2009: 102/1 (July) pp. 1-183

Journal:Thrombosis and Haemostasis
ISSN:0340-6245

Archive
Issue

32 articles
1.
Venous thromboembolism prophylaxis: Quality, location (hospital vs. home), and duration

Samuel Z. Goldhaber

Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachussetts, USA

Thrombosis and Haemostasis 2009 102 1: 1-2

http://dx.doi.org/10.1160/TH09-05-0292

[Summary] [Free download]
2.
Ex-vivo thrombolytic gene therapy for vein graft patency: The frontier for development of selective, localised therapeutic approaches

Christoph E. Hagemeyer; Karlheinz Peter

Atherothrombosis and Vascular Biology, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia

Thrombosis and Haemostasis 2009 102 1: 3-4

http://dx.doi.org/10.1160/TH09-06-0343

[Summary] [Free download]
3.
Safety of venous ultrasound in suspected DVT – still a matter of concern?

Jan Beyer-Westendorf

University Clinic “Carl Gustav Carus”, Division of Vascular Medicine, Technical University Dresden, Dresden, Germany

Thrombosis and Haemostasis 2009 102 1: 5-6

http://dx.doi.org/10.1160/TH09-04-0233

[Summary] [Free download]
4.
[Add to basket]
Clopidogrel response variability: Current status and future directions

José Luis Ferreiro; Dominick J. Angiolillo

University of Florida College of Medicine-Jacksonville, Jacksonville, Florida, USA

Thrombosis and Haemostasis 2009 102 1: 7-14

http://dx.doi.org/10.1160/TH09-03-0185

[Summary] [PDF] [Pay per view]
5.
Recent developments in topical thrombins

Craig M. Kessler1; Thomas L. Ortel2

1Division of Coagulation, Department of Laboratory Medicine, Georgetown University, Washington, DC, USA; 2Hemostasis and Thrombosis Center, Duke University, Durham, North Carolina, USA

Thrombosis and Haemostasis 2009 102 1: 15-24

http://dx.doi.org/10.1160/TH09-01-0034

[Summary] [Free download]
6.
[Add to basket]
Laboratory criteria of the obstetrical antiphospholipid syndrome - Data from a multicentric prospective European women cohort

Marie-Claire Boffa1; Catherine Boinot2; Sara De Carolis3; Patrizia Rovere-Querini4; Marie-Hélène Aurousseau1; Flavio Allegri5; Pascale Nicaise-Roland1,6; Anne Barra7; Angela Botta8; Ales Ambrozic9; Tadej Avcin10; Angela Tincani5

1Laboratoire d’Hématologie, Unité Hémostase et Thrombose, AP- Hôpitaux de Paris, Hôpital Jean-Verdier, Bondy, France; 2 Service d’Hématologie et Oncologie Biologique, Centre Hospitalier et Université de Poitiers, Poitiers, France; 3Department of Obstetrics and Gynecology, Catholic University, Rome, Italy; 4San Raffaele Scientific Institute, Milano, Italy; 5Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy; 6Immunologie, AP-HP Hôpital Bichat, Claude Bernard, Paris, France; 7Laboratoire d'Immunologie, Centre Hospitalier et Université de Poitiers, Poitiers, France; 8Department of Rheumatology and Immunology, Catholic University, Rome, Italy; 9Department of Rheumatology and Immunology, University Medical Center, Ljubljana, Slovenia; 10Pediatrics, University Medical Center, Ljubljana, Slovenia

Thrombosis and Haemostasis 2009 102 1: 25-28

http://dx.doi.org/10.1160/TH09-01-0043

[Summary] [PDF] [Pay per view]
7.
[Add to basket]
Demonstration of heterodimeric fibrinogen molecules partially conjugated with albumin in a novel dysfibrinogen: Fibrinogen Mannheim V

Carl-Erik Dempfle1; Peter M.George2; Martin Borggrefe1; Michael Neumaier3; Stephen O. Brennan2

1University Hospital of Mannheim, I. Department of Medicine, Mannheim, Germany; 2Molecular Pathology Laboratory, Canterbury Health Laboratories, Christchurch Hospital, Christchurch, New Zealand; 3University Hospital of Mannheim, Department of Clinical Chemistry, Mannheim, Germany

Thrombosis and Haemostasis 2009 102 1: 29-34

http://dx.doi.org/10.1160/TH08-09-0559

[Summary] [PDF] [Pay per view]
8.
[Add to basket]
The comparative immunogenicity of human and porcine factor VIII in haemophilia A mice

John F. Healey1; Ernest T. Parker1; Rachel T. Barrow1; Travis J. Langley1; William R. Church2; Pete Lollar1

1Aflac Cancer Center and Blood Disorders Service, Department of Pediatrics, Children’s Healthcare of Atlanta and Emory University, Atlanta, Georgia, USA; 2Green Mountain Antibodies, Burlington, Vermont, USA

Thrombosis and Haemostasis 2009 102 1: 35-41

http://dx.doi.org/10.1160/TH08-12-0818

[Summary] [PDF] [Pay per view]
9.
[Add to basket]
Differential inhibition of thrombin generation by vitamin K antagonists alone and associated with low-molecular-weight heparin

Grigoris T. Gerotziafas1,2; Charlotte Dupont1; Alex C. Spyropoulos3; Mohamed Hatmi4; Meyer M. Samama4; Dimitris Kiskinis5; Ismail Elalamy1,2

1Service d’Hématologie Biologique, Hôpital Tenon, Assistance Publique Hôpitaux de Paris, France; 2ER2UPMC, Faculty of Medicine, University Pierre and Marie Curie (Paris VI), France; 3Clinical Thrombosis Center, Lovelace Medical Center, Albuquerque, New Mexico, USA; 4Service d’Hématologie Biologique, Hôpital Hôtel Dieu, Assistance Publique Hôpitaux de Paris, Université Pierre et Marie Curie (Paris VI), France; 5Research Unit of Thrombosis and Vascular Biology, 1st Department of Surgery, Aristotle University of Thessaloniki, Papageorgiou general Hospital, Thessaloniki, Greece

Thrombosis and Haemostasis 2009 102 1: 42-48

http://dx.doi.org/10.1160/TH08-10-0653

[Summary] [PDF] [Pay per view]
10.
[Add to basket]
Hypercoagulability is independently associated with kynurenine pathway activation in dialysed uraemic patients

Krystyna Pawlak1; Michal Mysliwiec2; Dariusz Pawlak1,3

1Department of Monitored Pharmacotherapy, Medical University, Bialystok, Poland; 2Department of Nephrology and Clinical Transplantation, Medical University, Bialystok, Poland; 3Department of Medical Science, University of Warmia and Mazury, Olsztyn, Poland

Thrombosis and Haemostasis 2009 102 1: 49-55

http://dx.doi.org/10.1160/TH08-10-0696

[Summary] [PDF] [Pay per view]
11.
[Add to basket]
Lack of extended venous thromboembolism prophylaxis in high-risk patients undergoing major orthopaedic or major cancer surgery - Electronic Assessment of VTE Prophylaxis in High-Risk Surgical Patients at Discharge from Swiss Hospitals (ESSENTIAL)

Christoph Kalka1*; David Spirk2*; Klaus-Arno Siebenrock1; Urs Metzger3; Philipp Tuor4; Daniel Sterzing5; Kurt Oehy6; Daniela Wondberg7; El Yazid Mouhsine8; Emanuel Gautier9; Nils Kucher10

1University Hospital Berne, Switzerland; 2sanofi-aventis (suisse) sa Meyrin, Switzerland; 3City Hospital Triemli Zurich, Switzerland; 4City Hospital Waid Zurich, Switzerland; 5Cantonal Hospital Muensterlingen, Switzerland; 6Cantonal Hospital Frauenfeld, Switzerland; 7Cantonal Hospital Olten, Switzerland; 8University Hospital Lausanne, Switzerland; 9Cantonal Hospital Fribourg, Switzerland; 10University Hospital Zurich, Switzerland

Thrombosis and Haemostasis 2009 102 1: 56-61

http://dx.doi.org/10.1160/TH09-02-0097

[Summary] [PDF] [Pay per view]
12.
[Add to basket]
Anticoagulant mechanisms of covalent antithrombin-heparin investigated by thrombelastography - Comparison with unfractionated heparin and low-molecular-weight heparin

Helen M. Atkinson1,2; Tracy A. Mewhort-Buist1,2; Leslie R. Berry1,2; Anthony K. C. Chan1,2

1Henderson Research Centre, Hamilton, ON, Canada; 2Department of Pediatrics, McMaster University, Hamilton, ON, Canada

Thrombosis and Haemostasis 2009 102 1: 62-68

http://dx.doi.org/10.1160/TH08-11-0769

[Summary] [PDF] [Pay per view]
13.
[Add to basket]
Comparative study of inhibitory antibody derivatives towards thrombin activatable fibrinolysis inhibitor

Jan Develter; Maarten Dewilde; Ann Gils; Paul J. Declerck

Laboratory for Pharmaceutical Biology, Faculty of Pharmaceutical Sciences, Katholieke Universiteit Leuven, Belgium

Thrombosis and Haemostasis 2009 102 1: 69-75

http://dx.doi.org/10.1160/TH08-09-0834

[Summary] [PDF] [Pay per view]
14.
[Add to basket]
Absence of platelet-dependent fibrin formation in a patient with Scott syndrome

Simone J. H. Wielders1; Jos Broers2; Hugo ten Cate3; Peter W. Collins4; Edouard M. Bevers1; Theo Lindhout1

1Department of Biochemistry, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands; 2Department of Molecular Cell Biology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands; 3Department of Internal Medicine, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands; 4Arthur Bloom Haemophilia Centre, University Hospital of Wales, Cardiff, United Kingdom

Thrombosis and Haemostasis 2009 102 1: 76-82

http://dx.doi.org/10.1160/TH08-11-0719

[Summary] [PDF] [Pay per view]
15.
[Add to basket]
Binding of plasma factor XIII to thrombin-receptor activated human platelets

Béla Nagy Jr1; Zsuzsa Simon1; Zsuzsa Bagoly2; László Muszbek2; János Kappelmayer1

1Department of Clinical Biochemistry and Molecular Pathology, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary; 2Clinical Research Center and Thrombosis, Haemostasis and Vascular Biology Research Group, Hungarian Academy of Sciences, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary

Thrombosis and Haemostasis 2009 102 1: 83-89

http://dx.doi.org/10.1160/TH09-01-0054

[Summary] [PDF] [Pay per view]
16.
[Add to basket]
Megakaryocytes of patients with MYH9-related thrombocytopenia present an altered proplatelet formation

Alessandro Pecci1; Alessandro Malara2; Stefania Badalucco2; Valeria Bozzi1; Mauro Torti2; Carlo L. Balduini1; Alessandra Balduini2

1Department of Internal Medicine, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy; 2Department of Biochemistry, IRCCS Policlinico San Matteo Foundation, University of Pavia, Pavia, Italy

Thrombosis and Haemostasis 2009 102 1: 90-96

http://dx.doi.org/10.1160/TH09-01-0068

[Summary] [PDF] [Pay per view]
17.
[Add to basket]
Immune versus thrombotic stimulation of platelets differentially regulates signalling pathways, intracellular protein-protein interactions, and α-granule release

Sybille Rex1,2; Lea M. Beaulieu1; David H. Perlman2; Olga Vitseva1; Price S. Blair1; Mark E. McComb2; Catherine E. Costello2,3; Jane E. Freedman1,2

1Whitaker Cardiovascular Institute, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA; 2Cardiovascular Proteomics Center, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA; 3Mass Spectrometry Resource and Department of Biochemistry, Boston University School of Medicine, Boston, Massachusetts, USA

Thrombosis and Haemostasis 2009 102 1: 97-110

http://dx.doi.org/10.1160/TH08-08-0513

[Summary] [PDF] [Pay per view]
18.
[Add to basket]
The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease

Victor L. Serebruany1; Motoji Kogushi2; Daniela Dastros-Pitei3; Marcus Flather4; Deepak L. Bhatt5

1HeartDrug™ Research Laboratories, Johns Hopkins University Baltimore, MD, USA; 2Innovative Biology Laboratories, Eisai Co. Ltd., Tsukuba, Japan; 3Eisai Global Clinical Development, Eisai Limited, London, UK; 4Royal Brompton Hospital and Imperial College, London, UK; 5VA Boston Healthcare System and Brigham and Women’s Hospital, Boston, Massachussetts, USA

Thrombosis and Haemostasis 2009 102 1: 111-119

http://dx.doi.org/10.1160/TH08-12-0805

[Summary] [PDF] [Pay per view]
19.
[Add to basket]
The absence of angiopoietin-2 leads to abnormal vascular maturation and persistent proliferative retinopathy

- See additional contents by clicking on [Summary] -

Yuxi Feng1; Franziska vom Hagen1; Yumei Wang1; Susanne Beck2; Kay Schreiter3; Frederick Pfister1; Sigrid Hoffmann4; Patrick Wagner5; Mathias Seeliger2; Grietje Molema6; Urban Deutsch7; Hans-Peter Hammes1

15th Medical Clinic, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; 2Retinal Electrodiagnostics Research Group, University of Tuebingen, Tuebingen, Germany; 3DeveloGen AG, Göttingen, Germany; 4Medical Research Center, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany; 5Max-Planck-Institute for Physiological and Clinical Research, Bad Nauheim, Germany; 6Laboratory for Endothelial Biomedicine and Vascular Drug Targeting Research, Medical Biology Section, Department Pathology and Laboratory Medicine, University Medical Center Groningen, University of Groningen, Groningen, Netherlands; 7Max-Planck-Institute for Vascular Biology, c/o Institute of Cell Biology, ZMBE, University of Muenster, and Theodor-Kocher-Institute, Berne, Switzerland

Thrombosis and Haemostasis 2009 102 1: 120-130

http://dx.doi.org/10.1160/TH08-09-0567

[Summary] [PDF] [Pay per view]
20.
[Add to basket]
Rare genotypes of protein Z gene are a risk factor for premature myocardial infarction but not protein Z plasma level

Véronique Le Cam-Duchez1,2; Claudine Soria2,3; Claire Bal dit Sollier3; Jeanne-Yvonne Borg1,2; Mathieu Coudert4,5; Gilles Montalescot6; Gaétan Esposito3; Ludovic Drouet3; Jean-Philippe Collet6

1Unit of Vascular Haemostasis, Rouen University Hospital, Rouen, France; 2EA3829 (Research Group MERCI), Institute for Biomedical Research, University of Rouen, Rouen, France; 3Haematology Laboratory, Lariboisière University Hospital, Paris, France; 4APHP, Pitié-Salpêtrière Charles-Foix Clinical Research Unit, Paris, France; 5UPMC Univ. Paris 06, EA 3974, Modelling in Clinical Research, Paris, France; 6Department of Cardiology, Pitié-Salpêtrière University Hospital, Paris, France

Thrombosis and Haemostasis 2009 102 1: 131-136

http://dx.doi.org/10.1160/TH09-01-0007

[Summary] [PDF] [Pay per view]
  1-20 21-32
Next page

Articles

You've 575 Article(s) in your Basket.

Thrombosis News

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...